MS patients denied licensed cannabis drug by NHS
MS patients denied licensed cannabis drug by NHS
The NHS has been criticised by doctors for denying multiple sclerosis patients access to a drug derived from cannabis which regulators have approved to help relieve their symptoms.
MS specialists claim primary care trusts (PCTs) in England are exacerbating patients' pain and suffering by refusing to let them use Sativex. Some PCTs say the drug, which costs £11 a day, is not worth the money, but doctors insist it is the only medication that can help some patients.
Sativex can relieve spasticity, or muscle stiffness, in MS patients. It became the first cannabis-based medicine to be licensed for use in the UK almost a year ago by the Medicines and Healthcare products Regulatory Agency (MHRA). ... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1814
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1445 Views
-
Last post by frodo
-
- 0 Replies
- 1464 Views
-
Last post by NHE
-
- 0 Replies
- 468 Views
-
Last post by NHE
-
- 0 Replies
- 1440 Views
-
Last post by NHE
-
- 1 Replies
- 2908 Views
-
Last post by Tif
-
- 0 Replies
- 2233 Views
-
Last post by frodo
-
- 5 Replies
- 13340 Views
-
Last post by gibbledygook
-
- 2 Replies
- 854 Views
-
Last post by DIM
-
- 1 Replies
- 1783 Views
-
Last post by raceya